MON-265 Once-Weekly Somapacitan in Japanese Adults with GH Deficiency Was Well Tolerated, with Similar Efficacy to Daily GH: A Randomized Trial

Somapacitan is a long-acting, reversible albumin-binding human growth hormone (GH) derivative based on a proven protraction technology. The objective of this trial was to evaluate the safety, efficacy and treatment satisfaction of once-weekly somapacitan compared with daily GH (Norditropin®) over 52...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Otsuka, Fumio, Takahashi, Yutaka, Tahara, Shigeyuki, Rasmussen, Michael Højby, Ogawa, Yoshihisa, Takano, Koji
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Neuroendocrinology and Pituitary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209108/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.605
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars